2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
Medicare on the Move: Why a Medicare Prescription Payment Plan (MPPP) Program Audit is Critical
Mitigate Risk with a Smart MPPP Program Audit The world of Medicare Part D underwent a significant transformation with the introduction of the…
Read Post
Modular PBA: Reimagining Pharmacy Benefits For Employers
Understand Important Components of a Modular PBA Strategy for Employers In 2023, Blue Shield of California (BSC) announced a new pharmacy supply chain…
Read Post
Pharmacy Benefits Explained: A Guide To The Modular PBA Model
Learn About the Modular PBA Model and Considerations for Payers in This Guide What is a Modular PBA Model? A Modular PBA…
Read Post
2025 Trends in Drug Benefit Design Report Webinar
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Payers Seeking Innovative Solutions to Control Specialty Drug Costs as Pharmacy Benefit Landscape Evolves Rapidly
New Survey Reveals 84% of Payers Prioritize Total Cost Management as Cell and Gene Therapies Present Unprecedented Challenges DALLAS, TX – Employers and health…
Read Post
2025 Trends in Specialty Drug Benefits Report
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to…
Read Post
2026 Medicare Final Rule: Key Implications for Health Plan Pharmacy Leaders
The Centers for Medicare & Medicaid Services (CMS) has released its final rule outlining significant pharmacy changes for Medicare and…
Read Post
OptumRx Prior Authorization Changes: What Does It Actually Mean For Patients, Providers, and Payers
Understand Considerations for OptumRx’s PA Announcement OptumRx (Optum) recently announced significant changes to its prior authorization program, eliminating the reauthorization process for 80…
Read Post
Learnings from the Latest Pharmacy Benefit Fiduciary Lawsuit Developments
Proactive Pharmacy Benefit Oversight in an Evolving Legal Landscape In the first quarter of 2025, plan fiduciaries witnessed significant news about and movement on…
Read Post
2025 Trends in Specialty Drug Benefits Report Webinar
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to…
Read Post
Empowering Health Plans with Innovative Solutions to Accelerate PBM Transparency
As a health plan pharmacy leader, you steward millions if not billions in annual pharmacy spend. Yet, as you know, translating complex Pharmacy Benefit…
Read Post